Dr Sleeboom-Faulkner has been developing SMAP since 2003. She co-ordinates the research projects to enable comparison regarding the application of the new genetic technologies in the fields of reproductive genetics and genetic sampling and biobanking in China, Japan and India. Over the next five years it should become clear which groups and individuals may be regarded as vulnerable in these fields. SMAP aims to produce insights that open up possibilities for new insights in the areas of policy-making, regulation or public debate, and will indicate promising areas of future research. Sleeboom's own research focuses mainly in biobanking and genetic counselling in China and Japan.

2001 Genomics in Asia. A Clash of Bioethical Interests? Kegan Paul: London, New York, Bahrain - 20042007 The Chinese Academy of Social Sciences (CASS). Shaping the Reforms, Academia and China (1977-2003). Brill Academic Publishers